Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 19% ± 3% | |
cardiac muscle cell | 4 studies | 27% ± 2% | |
epithelial cell | 3 studies | 24% ± 4% | |
type II pneumocyte | 3 studies | 19% ± 2% | |
GABAergic neuron | 3 studies | 37% ± 5% | |
glutamatergic neuron | 3 studies | 47% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5029.23 | 245 / 245 | 100% | 71.56 | 502 / 502 |
intestine | 100% | 4580.71 | 964 / 966 | 98% | 35.72 | 516 / 527 |
stomach | 99% | 3602.86 | 356 / 359 | 98% | 33.53 | 281 / 286 |
breast | 100% | 5286.83 | 459 / 459 | 97% | 66.47 | 1087 / 1118 |
thymus | 100% | 4854.04 | 651 / 653 | 97% | 51.59 | 587 / 605 |
adrenal gland | 100% | 6548.58 | 258 / 258 | 96% | 39.98 | 221 / 230 |
brain | 96% | 2746.54 | 2539 / 2642 | 99% | 37.30 | 698 / 705 |
ovary | 98% | 2586.31 | 176 / 180 | 93% | 23.33 | 402 / 430 |
bladder | 100% | 7239.14 | 21 / 21 | 91% | 43.66 | 457 / 504 |
lung | 98% | 3730.36 | 566 / 578 | 92% | 33.48 | 1068 / 1155 |
pancreas | 93% | 1944.85 | 306 / 328 | 95% | 24.28 | 169 / 178 |
esophagus | 100% | 5483.90 | 1444 / 1445 | 87% | 23.82 | 159 / 183 |
kidney | 99% | 2969.24 | 88 / 89 | 88% | 34.06 | 792 / 901 |
uterus | 98% | 2945.35 | 167 / 170 | 85% | 23.87 | 389 / 459 |
skin | 82% | 1854.73 | 1476 / 1809 | 95% | 37.25 | 448 / 472 |
muscle | 100% | 15118.21 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.43 | 1 / 1 |
blood vessel | 100% | 5561.49 | 1331 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 5377.32 | 1197 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 1908.65 | 236 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 13210.82 | 825 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 23.38 | 37 / 45 |
eye | 0% | 0 | 0 / 0 | 78% | 19.51 | 62 / 80 |
lymph node | 0% | 0 | 0 / 0 | 76% | 13.80 | 22 / 29 |
liver | 0% | 6.89 | 1 / 226 | 21% | 3.50 | 87 / 406 |
peripheral blood | 6% | 67.53 | 52 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000649 | Biological process | regulation of sodium ion transmembrane transporter activity |
GO_0090038 | Biological process | negative regulation of protein kinase C signaling |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0086005 | Biological process | ventricular cardiac muscle cell action potential |
GO_0002027 | Biological process | regulation of heart rate |
GO_0060373 | Biological process | regulation of ventricular cardiac muscle cell membrane depolarization |
GO_2000010 | Biological process | positive regulation of protein localization to cell surface |
GO_0046168 | Biological process | glycerol-3-phosphate catabolic process |
GO_0006116 | Biological process | NADH oxidation |
GO_0019674 | Biological process | NAD metabolic process |
GO_0010765 | Biological process | positive regulation of sodium ion transport |
GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0051287 | Molecular function | NAD binding |
GO_0047952 | Molecular function | glycerol-3-phosphate dehydrogenase [NAD(P)+] activity |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0017080 | Molecular function | sodium channel regulator activity |
GO_0141152 | Molecular function | glycerol-3-phosphate dehydrogenase (NAD+) activity |
Gene name | GPD1L |
Protein name | Glycerol-3-phosphate dehydrogenase 1 like Glycerol-3-phosphate dehydrogenase [NAD(+)] (EC 1.1.1.8) Glycerol-3-phosphate dehydrogenase 1-like protein (GPD1-L) (EC 1.1.1.8) |
Synonyms | KIAA0089 |
Description | FUNCTION: Plays a role in regulating cardiac sodium current; decreased enzymatic activity with resulting increased levels of glycerol 3-phosphate activating the DPD1L-dependent SCN5A phosphorylation pathway, may ultimately lead to decreased sodium current; cardiac sodium current may also be reduced due to alterations of NAD(H) balance induced by DPD1L. . |
Accessions | ENST00000425459.5 ENST00000282541.10 Q8N335 C9JFA7 F8WC16 ENST00000428684.1 ENST00000429432.5 C9K0P5 C9JM46 ENST00000431009.1 |